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Abstract 
Malassezia furfur is lipophilic and lipid-dependent yeast, inhabitant of human skin microbiota associated with several 
dermal disorders. In recent years, along with the advances in nanotechnology and the incentive to find new antimi-
crobial drugs, there has been a growing interest in the utilization of nanoparticles for the treatment of skin microbial 
infections. This work aimed to study the in vitro inhibitory activity of silver nanoparticles (AgNP) against 41 M. furfur 
clinical isolates, visualize the interaction between AgNP-Malassezia, evaluate the synergism with ketoconazole (KTZ) 
and to produce an antimicrobial gel of AgNP–KTZ. The synthesized AgNP were randomly distributed around the yeast 
surface and showed a fungicidal action with low minimal inhibitory concentration values. AgNP showed no antago-
nistic effect with KTZ. The broad-spectrum antimicrobial property with fungicidal action of AgNP and its accumula-
tion in affected areas with a sustained release profile, added to the great antifungal activity of KTZ against Malassezia 
infections and other superficial mycoses, allowed us to obtain a gel based on carbopol formulated with AgNP–KTZ 
with the potential to improve the topical therapy of superficial malasseziosis, reduce the number of applications and, 
also, prevent the recurrence.
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Introduction
Yeasts of Malassezia genus are normal inhabitants of the 
human skin microbiota and other warm-blooded verte-
brates. Since they are unable to synthesize fatty acids, all 
Malassezia species are lipophilic and most of them lipid-
dependent, requiring an external source of lipids. For 
this reason, they prevail in body areas rich in sebaceous 
glands (Boekhout et al. 2010).
These yeasts are considered to be the etiological agent 
of pityriasis versicolor and Malassezia folliculitis, associ-
ated agents in seborrheic dermatitis/dandruff and a con-
tributory factor that exacerbate other skin disorders such 
as atopic dermatitis, psoriasis, confluent and reticulate 
papillomatosis, and neonatal pustulosis (Giusiano 2006; 
Boekhout et  al. 2010; Saunders et  al. 2012; Rojas et  al. 
2014; Rudramurthy et al. 2014; Prohic et al. 2016). Cuta-
neous diseases associated with Malassezia are often 
chronic and recurrent. In these cases, the results of anti-
fungal therapy, both topical and systemic, are not always 
effective due to high relapse rates (Giusiano et  al. 2010; 
Carrillo-Muñoz et al. 2013; Prohic et al. 2016; Rojas et al. 
2016).
Topical antifungal medications are the first-line treat-
ment for Malassezia infections, and ketoconazole (KTZ) 
is one of the most effective antifungal agents. KTZ 
is a fungistatic imidazole that inhibits the lanosterol 
14α-demethylase, an enzyme that regulates the synthe-
sis of ergosterol. The disruption of ergosterol biosynthe-
sis alters cell membrane structure, thus compromising 
membrane integrity and permeability and consequently 
interfering with cellular growth and reproduction. KTZ 
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was the first broad-spectrum antifungal used in the treat-
ment of superficial mycoses (Gupta and Foley 2015).
Nanotechnology is an important field of modern 
research which deals with synthesis and manipulation 
of structures of matter ranging from approximately 1 
to 100 nm in size, commonly called nanomaterials (Liz-
Marzán and Kamat 2003; Rao et  al. 2004). The noble 
metal nanoparticles showed unique and considerably 
different physical and chemical properties compared 
to their macro scaled counterparts (Feldheim and Foss 
2002). As the size of the nanoparticles decreased, their 
surface-volume ratio and antimicrobial activity increased 
(Rai et al. 2009; Sharma et al. 2009; Song and Kim 2009; 
Bera et al. 2014; Ahmed et al. 2016). Silver (Ag) is one of 
the noble metals with higher antimicrobial activity and 
lower toxicity for animal cells (ATSDR 1990; Lansdown 
2010).
There has been a growing interest in silver nanoparti-
cles (AgNP) over the years due to their potential appli-
cation in human and animal medicine for treating skin 
infections including dermatomycosis (Rai et al. 2009; Ge 
et al. 2014; Aljuffali et al. 2015). Likewise, these particles 
either alone or in combination with other drugs, would 
represent a therapeutic alternative against resistant 
microorganisms, as well as in complications associated 
with the use of antifungals (Rai et  al. 2009, 2012; Bera 
et al. 2014).
Clinical and Laboratory Standards Institute (CLSI) 
document M27-A3, describes a broth microdilution 
method for testing the in  vitro antifungal susceptibil-
ity for Candida species and Cryptococcus neoformans 
for the determination of minimal inhibitory concentra-
tions (MIC) (Clinical and Laboratory Standards Institute 
2008). Due to the nutritional requirements of Malasse-
zia yeasts, this method is not applicable for this genus. 
Rojas et al. (2014) proposed a nutritionally supplemented 
medium to evaluate the in  vitro activity of antifungals 
against some Malassezia species.
The aims of this study were to: (a) study the in  vitro 
inhibitory activity of AgNP synthesized against Malasse-
zia furfur clinical isolates, (b) evaluate this activity in 
combination with KTZ, (c) visualize the interaction 
between AgNP-Malassezia and (d) produce and evaluate 
the activity of an antimicrobial gel of AgNP–KTZ.
Materials and methods
Synthesis of silver nanoparticles
AgNP were synthesized by chemical reduction of  AgNO3 
in ethanol, according to Roldán et al. (2008), with some 
modifications as described as follow.  AgNO3 (Merck) was 
dissolved in ethanol absolute (Ciccarelli) under ultra-
sound stirring. Ethanol was used as solvent and also as a 
mild reducing agent. On the other hand, the aminosilane 
[N-[3-(trimethoxysilyl) propyl] diethylenetriamine] 
(ATS, Aldrich) was dissolved in ethanol absolute under 
 N2 atmosphere and magnetic stirring. Then, both solu-
tions were mixed and homogenized obtaining a final 
solution of 12 mM of  AgNO3 and 0.197 M of ATS. This 
solution was placed at a temperature bath at 40 °C under 
 N2 atmosphere for 4 h. The color of the solution changed 
from uncolored to bright yellow.
Characterization of silver nanoparticles
It was carried out by UV–Vis absorption spectroscopy 
and transmission electron microscopy (TEM).
Optical characterization of colloidal suspensions was 
performed by UV–Vis absorption spectroscopy, using 
UV/Vis spectrophotometer (Jasco V-530). UV–Vis spec-
tra were acquired by employing ethanol as reference. The 
colloidal stability of AgNP over time was evaluated by 
visual observation and UV–Vis spectroscopy.
TEM images were acquired with a Phillips 100  keV. 
Samples were prepared by dropping the nanoparticles 
suspension over a carbon coated TEM grid. Several TEM 
images were processed with ImageJ free software to esti-
mate mean size and standard deviation.
Microorganisms
A total of 40 M. furfur isolates were studied. Isolates were 
obtained from human clinical samples with diagnosis of 
pityriasis versicolor, seborrhoeic dermatitis/dandruff and 
atopic dermatitis. All Malassezia yeasts were deposited 
in the culture collection of Mycology Department, Insti-
tuto de Medicina Regional (IMR), Universidad Nacional 
del Nordeste (UNNE), Argentina. Identification was per-
formed by polymerase chain reaction-restriction frag-
ment length polymorphism (PCR–RFLP) (Mirhendi et al. 
2005; Sosa et  al. 2013). In addition, the reference strain 
M. furfur CBS 7019 was included.
Isolates were sub-cultured for 72  h onto modified 
Dixon Agar at 32  °C before antifungal susceptibility 
testing.
Minimum inhibitory concentration (MIC)
In order to evaluate the inhibitory activity of synthe-
sized AgNP and KTZ (Sigma-Aldrich, Buenos Aires, 
Argentina), MIC were determined by broth microdilu-
tion method in accordance with CLSI M27-A3 document 
(Clinical and Laboratory Standards Institute 2008) with 
modifications proposed by Rojas et al. (2014).
All inoculum suspensions were prepared in ster-
ile saline solution and turbidity was adjusted to a 1 
McFarland scale by densitometer (DEN-1 densitometer, 
Biosan). This inoculum was diluted 1:100 in supple-
mented RPMI medium to achieve a final concentration of 
0.5–2.5 × 105 CFU/mL.
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AgNP and KTZ solutions were prepared using dime-
thyl sulfoxide (DMSO) as solvent (final concentration 
≤ 1%) and RPMI medium as diluents. A twofold dilution 
serial of the drugs was performed to obtain a final con-
centration range from 4 to 0.008  mg/L. The microtiter 
plates with 96  U wells (Greiner bio-One, Buenos Aires, 
Argentina) were incubated for 3 days at 32 °C.
MIC for AgNP solution was determined by visual read-
ing of growth inhibition at two endpoints: MIC-2 as the 
lowest concentration capable of inhibiting ≥ 50% growth 
as compared with the AgNP-free growth-control well and 
MIC-0 as the lowest concentration that completely inhibit 
yeast growth. For KTZ, the MIC endpoint was MIC-2 
(Clinical and Laboratory Standards Institute 2008).
Visualization of interaction AgNP‑Malassezia
To observe the yeasts after treatment with AgNP, 10  µL 
were taken from the well corresponding to a MIC-2 for 
M. furfur CBS 7019 and placed on a clean and sterile glass 
surface. After drying at 35 °C under sterile conditions, cells 
were fixed with a solution of formaldehyde–alcohol–acetic 
acid (FAA) for 24  h. Subsequently, dehydration was car-
ried out using an ethanol gradient, critical point drying 
in  CO2 and gold coating. Samples were examined under a 
Jeol 5800 LV (Tokyo, Japan) scanning electron microscope 
(SEM) at Servicio de Microscopía Electrónica (Universi-
dad Nacional del Nordeste, Argentina).
Minimum fungicidal concentration (MFC)
The MFC of AgNP solution was determined following 
procedures of Cantón et  al. (2003) with modifications. 
After the MIC was read, the content of each well was 
homogenized with a micropipette and the entire volume 
(200  µL) of these wells was subcultured onto modified 
Dixon agar plates of 90 × 15  mm. Aliquots were depos-
ited as a spot onto the agar and after the plate was dry, 
streaking was performed. All plates were incubated at 
32 °C for 72 h. The MFC was defined as the lowest drug 
concentration at which no colonies were observed (99.9% 
killing activity).
Since the AgNP mode of action is still unknown and 
there is no consensus on the endpoint reading, MIC-2, 
MIC-0 and the MFC were determined.
MFC/MIC ratios were calculated for each isolate using 
MIC-0 value. By extrapolation from the conventional 
definition used for bacterial testing, in this work, a com-
pound was considered fungicidal when the MFC/MIC 
ratio was ≤ 4 and fungistatic when the MFC/MIC ratio 
was > 4 (Hazen 1998; Pfaller et al. 2004; Meletiadis et al. 
2007).
MFC/MIC ratio allows us to determine if the isolate 
was tolerant to the compound. Tolerance occurs when 
a fungi is inhibited but not killed by an antifungal agent 
that normally is considered fungicidal, defined by a MFC/
MIC ratio > 32 (Pfaller et al. 2004).
All assays were performed in duplicate. The range, geo-
metric mean, mode, median, standard deviation,  MIC50 
and  MIC90 values defined as the lowest concentration at 
which 90% and 50% of all isolates tested were inhibited, 
were also obtained. Statistical analysis was carried out 
using InfoStat software provided by Cátedra de Estadís-
tica y Biometría, Facultad de Ciencias Agropecuarias, 
Universidad Nacional de Córdoba, Argentina.
Synergism
Checkerboard microdilution method was used to evalu-
ate the synergistic antifungal effect as a consequence of 
KTZ–AgNP interaction (Odds 2003). This assay was 
performed in 96-well microplates in which each row 
and each column contained twofold serial dilutions of 
KTZ and AgNP respectively, at concentrations around 
and below its MIC, reaching a unique combination of 
the two substances in each well. To evaluate combina-
tion of drugs against Malassezia, yeast inoculum, culture 
medium, temperature and incubation time, in identical 
conditions used to evaluate the in vitro inhibitory activ-
ity, were used.
Interactions were quantitatively evaluated by determin-
ing the fractional inhibitory concentration index (FICi) 
according to the formula (Meletiadis et  al. 2002; Odds 
2003):
FICi values were interpreted accordingly to Odds 
(2003) as: synergism (FICi ≤ 0.5), no interaction 
(FICi > 0.5–4.0) and antagonism (FICi > 4.0).
The FICi was determined for all the possible combina-
tions of different concentrations for each isolate.
Gels preparation
Four formulations of gels based on carbopol 940 (Merck) 
at 1.5% (w/w) were prepared. The formulation A con-
tained a final AgNP concentration of 0.03 mg/g; formula-
tion B contained a final KTZ concentration of 0.03 mg/g; 
formulation C contained a final AgNP and KTZ concen-
tration of 0.03 mg/g and 0.03 mg/g, respectively. Formu-
lation D without drugs was used as control.
Required quantity of carbopol 940 was weighed and dis-
persed slowly in the sterile purified water with continuous 
agitation. After that, the polymer was allowed to stand 
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for 24 h until it was completely wetted. The drug corre-
sponding to each formulation was added with continuous 
stirring till it was completely dispersed. Finally, the pH of 
the gel was adjusted to pH 7 using triethanolamine. The 
prepared gels were packaged under sterile conditions and 
stored in dark and cool place until time of use.
In vitro antifungal activity of gels
In order to evaluate the in vitro antifungal activity of the 
gel formulations by agar well diffusion method against 
M. furfur CBS 7019, 0.5  g of each gel containing 15  µg 
of each compound, was placed in a 6 mm diameter well 
separated by a distance of 2.5  cm. The inoculum size, 
culture medium, temperature and incubation time used 
were according to Rojas et al. methodology (Rojas et al. 
2016). The diameter of the inhibition zone was measured 
after incubation.
To observe whether the medium of support (carbopol 
940) modified the drugs activity, the disk diffusion assay 
against M. furfur CBS 7019 according to Rojas et  al. 
(2016) with modifications (Svetaz et  al. 2016) was per-
formed. Sterile Schleicher & Schuell 9  mm paper disks 
were embedded with 15 µg KTZ; others with 15 µg AgNP 
and a third disk with a mixture of both drugs (15  µg 
KTZ + 15  µg AgNP). A fourth disk without drugs was 
used as the control. Plates were incubated at 32  °C for 
72  h. The diameter of the inhibition zone around each 
disk was measured after incubation.
Results
The reduction of silver ions in different solutions gen-
erally yields colloidal silver with particle diameter 
of several nanometers and the yellow color is a result 
of the presence of few nanometers radius Ag nano-
spheres (Kreibig and Vollmer 1995). In this work, the 
yellow color of the colloidal silver was evidenced. UV–
Vis spectrum of synthesized colloidal nanoparticles 
showed a maximum absorption band at 408  nm, cor-
responding to the Local Surface Plasmon Resonance 
(LSPR) absorption typical of particles with nanometric 
size. AgNP were stable as colloids for at least 20 months 
without precipitation and color changes. TEM images 
showed spherical nanoparticles of 15 ± 4 nm diameter, 
measuring 100 particles from several images (Fig.  1). 
None agglomerated particles were observed.
Antifungal activity of AgNP and KTZ against M. fur-
fur evaluated by broth microdilution method showed 
in  vitro inhibitory activity against all isolates of M. 
furfur with MIC-2 values less to 0.5  mg/L. Also, KTZ 
showed values of geometric mean, mode,  MIC50 and 
 MIC90 lower than AgNP. However, the range obtained 
with AgNP was lower than KTZ (Table 1).
To date, there is no consensus on the MIC reading 
endpoint for AgNP against Malassezia, consequently, 
MIC-0 and MIC-2 were determined. Comparing MIC-0 
and MIC-2 data obtained with MFC for AgNP, MIC-0 
showed a wide dispersion of values but with range, geo-
metric mean, mode, median and standard deviation 
more similar to MFC (Table 1). In addition, 56.52% of 
MIC-2 values showed a difference of 3 or more dilu-
tions with respect to MFC. In contrast, differences ≤ 1 
dilution with respect to MFC were obtained in 100% of 
MIC-0. Therefore, the MIC-0 values were more consist-
ent with the MFC values.
Since it is unknown if AgNP has fungicidal or fungi-
static activity, the MFC/MIC ratios were calculated. 
Table  1 show that all ratios obtained were less than 4, 
suggesting that AgNP has fungicidal activity against M. 
furfur. Furthermore, no tolerance effect was evident.
Fig. 1 a Silver nanoparticles (AgNP) image acquired by transmission electron microscopy (TEM). b Size distribution calculated from several TEM 
images
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Applying SEM, micromorphology of M. furfur yeasts 
and the interaction AgNP-Malassezia could be observed 
as shown in Fig. 2. Nanoparticles adhere to the fungal cell 
wall with a non-specific distribution.
Checkerboard assay allowed to evaluate the effect of 
the combination of AgNP with KTZ against M. furfur. 
FICi values obtained are shown in Table  2. Interaction 
varied among different strains tested, 82.92% showed 
no-interaction effect (FICi > 0.5–4.0), while only 17.08% 
showed synergistic effect (FICi ≤ 0.5).
Inhibition zones diameters obtained by both diffusion 
assays for AgNP, KTZ and AgNP–KTZ against M. furfur 
CBS 7019 are summarized in Table 3 and can be observed 
in Fig. 3. AgNP–KTZ association showed a little increase 
in the inhibition zone compared to KTZ alone. However, 
this increase was higher using AgNP–KTZ in gel formu-
lation. The drug-free gel formulation showed no inhibi-
tion zone. Therefore, carbopol did not negatively modify 
the antifungal activity of drugs.
Discussion
In recent years, along with the advances in nanotechnol-
ogy and the incentive to find new antimicrobial drugs, 
there has been a growing interest in the utilization of 
nanoparticles for the treatment of skin microbial infec-
tions (Rai et al. 2014; Aljuffali et al. 2015). The antimicro-
bial properties of silver have been recognized and used as 
a standard treatment for bacterial skin infections caused 
by Staphylococcus aureus and Pseudomonas aeruginosa 
(Aljuffali et  al. 2015). On the other hand, AgNP have 
shown a broad-spectrum antimicrobial activity including 
fungal agents of opportunistic infections (Rai et al. 2014) 
such us Candida albicans, C. tropicalis, C. parapsilosis, 
C. glabrata (Panácek et al. 2009; Rahisuddin et al. 2015), 
Trichophyton rubrum (Kim et  al. 2008; Pereira et  al. 
2014), Trichosporon asahii (Xia et  al. 2014), Aspergillus 
niger, Rhizoctonia solani, Curvularia lunata, Colletotri-
chum sp. and Fusarium sp. (Bera et  al. 2014; Balaku-
maran et  al. 2015). However, some considerations must 
be taken into account in those reports. The synthesis 
Table 1 MFC, MIC-2 and  MIC-0 ranges, geometric mean (Gm), mode, median, standard deviation (Sd) and   MIC50 
and  MIC90 obtained for 41 M. furfur isolates
All MIC and MFC data are expressed in terms of mg/L
Range Gm Mode Median Sd MIC50 MIC90
AgNP MIC-2 0.06–0.25 0.11 0.12 0.12 0.06 0.12 0.25
AgNP MIC-0 0.12–2.00 0.51 1 0.5 0.54 0.50 1
AgNP MFC 0.25–2.00 0.74 1 1 0.69 – –
AgNP MFC/MIC 1.00–2.00 1.61 2.00 2.00 0.47 – –
KTZ 0.016–0.50 0.04 0.03 0.03 0.09 0.03 0.06
Fig. 2 Visualization of interaction between AgNP and M. furfur CBS 
7019 by SEM. The black arrows show the interaction of AgNP on the 
surface of Malassezia yeasts
Table 2 Values obtained of  interaction between  AgNP 
and KTZ against M. furfur using checkerboard assay
FICi Interpretation n Percentage (%)
0.375 Synergism 2 4.88
0.50 Synergism 5 12.20
0.75 No interaction 26 63.41
1.00 No interaction 8 19.51
Total 41 100
Table 3 Inhibition zone diameters (mm) of  the  different 





KTZ + AgNP 28 28
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methods used differs as well as the size and structure of 
the AgNP. Furthermore, in most of them, only a single 
isolate was used as a representative of the species.
In our work, AgNP were synthesized by a low cost sim-
ple continuous media (Roldán et al. 2008). ATS was used 
as a surface modifier and colloidal stabilizer, inhibiting 
the growth and avoiding agglomeration of reduced  Ag0, 
influencing the nanoparticles morphology and size. In 
addition, the use of aminosilanes has been shown to have 
a good biocompatibility for nanoparticles of different 
compositions (Zhu et al. 2012; Datta et al. 2017). There-
fore, the method applied in synthesizing AgNP allowed 
us to obtain stable particles with suitable size and shape, 
as well as characteristics associated with a consistent 
antimicrobial activity (Rai et al. 2014).
Ketoconazole (KTZ) was reported as one of the most 
active drugs against M. furfur, with low MIC and low 
variation in susceptibility values among different isolates. 
In contrast, high MIC and wide MIC ranges with flu-
conazole, miconazole and amphotericin B were reported 
(Garau et  al. 2003; Velegraki et  al. 2004; Miranda et  al. 
2007; Carrillo-Muñoz et  al. 2013; Rojas et  al. 2014). In 
this work, KTZ also showed a great inhibitory activity 
against M. furfur, with similar values than those reported 
in other studies (Carrillo-Muñoz et al. 2013; Rojas et al. 
2014, 2016). On the other hand, the in  vitro inhibitory 
activity of AgNP was similar to KTZ, showing an even 
more restricted MIC-2 range (Table  1). Also, 90% of all 
clinical isolates were inhibited at AgNP concentrations 
≤ 0.25 and 1 mg/L when MIC-2 and MIC-0 were used as 
the reading endpoint, respectively. These results show the 
strong antifungal activity of synthesized nanoparticles 
against these lipodependent yeasts.
The AgNP activity was tested against Malassezia yeasts 
using two endpoints. The application of a less rigorous 
endpoint, such as MIC-2, has been shown to consist-
ently represent the in vitro activity of some compounds 
(Clinical and Laboratory Standards Institute 2008); in 
addition, it sometimes provides a better correlation with 
the in  vivo behavior and with other measurements of 
antifungal activity such as the MFC (Klepser et al. 1998; 
Ernst et al. 2002). According to the data obtained, MIC-2 
values showed a lower dispersion than MIC-0 (Table 1). 
However, MIC-0 showed values of range, geometric 
mean, mode, median and standard deviation more simi-
lar to MFC, suggesting that MIC-0 is a better reading 
endpoint. On the other hand, according to considerations 
proposed in other studies regarding the MFC/MIC ratios 
(Hazen 1998; Pfaller et  al. 2004; Meletiadis et  al. 2007), 
it could be considered that AgNP has fungicidal action 
against M. furfur. Also, none of the isolates showed toler-
ance effect. Consequently, MIC-0 proved to be the best 
MIC reading endpoint for this compound against M. fur-
fur despite having a wider range, since MIC-2 is used for 
drugs with fungistatic action. However, it is necessary 
to correlate these values with other studies like time-kill 
assays to confirm the fungicidal action.
In applying SEM, it was observed that the nanoparticles 
adhered to the yeasts cell wall and showed a non-specific 
distribution, similar to that reported in bacteria and C. 
albicans (Chwalibog et al. 2010; Le et al. 2012; Vazquez-
Muñoz et  al. 2014; Lara et  al. 2015). It is believed that 
AgNP attach and anchor to the surface of the fungus and 
produce an increase of reactive oxygen species (ROS). 
This interaction causes structural changes and dam-








Fig. 3 Evaluation of the antifungal activity against M. furfur CBS 7019 by a disk diffusion and b agar well diffusion assay. I: KTZ; II: AgNP; III: 
KTZ + AgNP; C: control
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permeability and the membrane potential, forming pores 
causing ion leakage and other materials, depressing the 
activity of respiratory chain enzymes and, finally, lead-
ing to cell death (Hwang et  al. 2012; Vazquez-Muñoz 
et al. 2014; Lara et al. 2015). Also, it was shown that the 
accumulation of extracellular AgNP suggests a dynamic 
release of silver ions  (Ag+) by adjacent AgNP that actively 
penetrate the cell and lead to the intracellular biosyn-
thesis of AgNP. The interaction of AgNP with phospho-
rus- or sulphur-containing compounds as DNA and thiol 
groups of proteins can cause further damage of yeasts by 
inhibition of DNA replication and protein inactivation. 
Furthermore, the gradual release of  Ag+ by AgNP could 
have special relevance, as they may act as a reservoir 
increasing the duration of the antimicrobial effects (Le 
et al. 2012; Rai et al. 2012; Vazquez-Muñoz et al. 2014).
Topical antifungal medications are the first-line treat-
ment for superficial malasseziosis and KTZ is one of the 
most widely prescribed. However, treatment of fungal 
diseases such as pityriasis versicolor is not always effec-
tive, have a high recurrence rate and patient application 
compliance may be affected by multiple or laborious 
applications, especially in cases where large body areas 
are affected (Gupta and Foley 2015). On the other hand, 
the accumulation of AgNP in certain skin areas allow a 
sustained release of Ag at the infection site over a period 
of days or even weeks and with more concentration in 
hair follicles and sebaceous glands zones, where Malasse-
zia is more frequently located (Boekhout et  al. 2010; 
Aljuffali et al. 2015). Topical administrations of AgNP can 
persist more than 10  days on the skin, a more effective 
treatment can be obtained by reducing the number of 
applications that lead to greater patient compliance and, 
also, to avoid possible adverse effects associated with a 
frequent use. Moreover, the use of AgNP in association 
with KTZ would allow us to take advantage of the great 
antifungal activity of KTZ against Malassezia, even in 
other superficial mycoses, and the AgNP would broaden 
the antimicrobial spectrum and reduce the number of 
applications.
There are many studies about the combined use of 
AgNP with antibiotics; however, studies about the anti-
fungal effect of AgNP in combination with clinically-
used antifungal drugs are limited (Rai et  al. 2014). In 
the present study, AgNP and KTZ acted independently 
against most strains when used in combination. None 
antagonistic effect was detected, but synergistic was 
observed in 17.08% of the isolates (Table  2). The syn-
ergistic effect observed in some cases may be due 
to the fact that the AgNP acted as a carrier of KTZ, 
facilitating penetration into yeasts (Durán et al. 2011). 
These results highlight the importance of testing sev-
eral isolates of a species to evaluate the activity of 
antimicrobial drugs, especially combinations of them. 
Conclusive synergy results should not be obtained 
using a single strain.
In this work, based on the observed KTZ and AgNP 
capacities, we seek to take advantage of the benefits of 
the combined use against Malassezia to obtain a car-
bopol hydrogel containing AgNP and KTZ. Carbopol 
is a polymer of acrylic acid cross-linked with poly-
alkenyl ethers or divinyl glycol and is one of the most 
common thickening agents used by the pharmaceutical 
and cosmetic industry. Their rheological properties in 
the aqueous medium are well known and it is essen-
tially a non-toxic and non-irritating material for topi-
cal use (Das et al. 2013). There is concern that the silver 
ions applied to the skin could be absorbed by the sys-
temic circulation in significant amounts, which would 
increase the risk of poisoning. However, several toxic-
ity studies have shown that AgNP is completely safe for 
topical administration in concentrations sufficient to 
inhibit microbial growth (Alt et al. 2004; Jain et al. 2009; 
Jung et al. 2009; Brandt et al. 2012; Aljuffali et al. 2015). 
The inhibition zones obtained by both diffusion meth-
ods were concordant with the synergy assays. The com-
bined use of AgNP and KTZ showed a small increase in 
the inhibition zones, being slightly higher when the gel 
formulation was tested (Table 3 and Fig. 3). It was con-
firmed that the carbopol formulations obtained do not 
decrease the antifungal activity of the drugs tested. The 
drug-free carbopol gel proved to be inactive and a good 
support medium for both compounds.
As Malassezia form part of the skin microbiota, 
recurrence is particularly difficult to eradicate (Gupta 
and Foley 2015). Therefore, combination treatment 
of KTZ with AgNP may be promising in preventing 
the relapse. Also, antifungal clinical agents are limited 
and there are few topical medications with fungicidal 
activity, such as the synthesized AgNP in this work 
against M. furfur. The broad-spectrum of action of 
AgNP and its easy incorporation into a diversity of sup-
port medium such as creams, gels, shampoos, lotions, 
etc., opens the door to develop new formulations with 
potential clinical use (Rai et  al. 2009; Mijnendonckx 
et  al. 2013). Due to its sustained release profile, accu-
mulation in affected areas, hydro and liposoluble 
nature, stability and broad-spectrum antimicrobial 
property, association with KTZ can improve the topical 
therapy of superficial malasseziosis and, also, prevent 
its recurrence.
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